window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 25, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Genomics and sequencing

  • Artificial Intelligence,Clinical Development,Genomics and sequencing,Obesity,Precision medicine,Technology and platforms

    23andMe study links genetics to GLP-1 weight loss outcomes and side effects

    This Nature-published study from the 23andMe Research Institute identifies genetic [...]

    April 9, 2026
  • Diagnostics,Gastroenterology,Genomics and sequencing,Partnerships & Funding,Technology and platforms

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    March 25, 2026
  • Biotech,Cardiovascular diseases,Cell & Gene Therapy,Genomics and sequencing,Opthalmology,Partnerships & Funding

    Circio presents new in vivo data showing enhanced circVec-AAV gene expression in eye

    Circio Holding ASA, a biotechnology company developing circular RNA-based gene [...]

    February 27, 2026
  • Diagnostics,Genomics and sequencing,Research & Development,Technology and platforms

    New England Biolabs launches Monarch Mag Cell-free DNA extraction kit for scalable cfDNA isolation

    New England Biolabs has launched the Monarch Mag Cell-free DNA [...]

    February 15, 2026
  • Artificial Intelligence,Genomics and sequencing,Metabolic Diseases,Obesity,Research & Development

    Insitro completes first AI-enabled human genetics study of brown adipose tissue, identifies differentiated obesity targets

    insitro has completed what it says is the first population-scale [...]

    February 3, 2026
  • Data Management,Genomics and sequencing,Research & Development,Technology and platforms

    SPT Labtech adds automated Twist Bioscience NGS library preparation workflows to firefly platform

    SPT Labtech has announced the availability of validated automated workflows [...]

    January 15, 2026
  • Biotech,Cell & Gene Therapy,Genetic Diseases,Genomics and sequencing,Rare Diseases,Research & Development,Technology and platforms

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    January 13, 2026
  • Biologics & Biosimilars,Biotech,Clinical Development,Drug Development,Genomics and sequencing,Research & Development,Respiratory

    Flagship Pioneering signs new agreements with ProFound Therapeutics and Quotient Therapeutics with GSK collaboration

    Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]

    November 20, 2025
  • Artificial Intelligence,Genomics and sequencing,Research & Development

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    November 18, 2025
  • Chronic diseases,Drug Development,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development

    Ochre Bio and GSK complete research phase with large-scale human liver genomics datasets

    Ochre Bio has completed the research phase of its collaboration [...]

    November 18, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech, Clinical Trials, Drug discovery, Funding, Oncology, Partnerships & Funding, Pharmaceuticals and therapeutics, Research & Development, Technology and platforms
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Cardiovascular diseases, Chronic diseases, Market Access & Commercialization, Pharmaceuticals and therapeutics, Regulatory Affairs
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: CDMOs & Manufacturing, Drug Development, European biotech, Logistics and distribution, Oncology, Partnerships & Funding, Supply Chain & Logistics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top